A high serum KL-6 level (> 436 U/mL) was an independent predictor of the development of severe TR-ILD at the time of its onset, and a low serum KL-6 level with a high serum PCT or CRP level could exclude severe TR-ILD. This evidence concerns the gene CRP and interstitial lung disease.